NCT04037800

Brief Summary

The study is a prospective randomized controlled trail to compare early urinary continence recovery after robotic-assisted radical prostatectomy with or without sustainable functional urethral reconstruction (SFUR).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable prostate-cancer

Timeline
Completed

Started Dec 2019

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

December 8, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2021

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

1.1 years

First QC Date

July 24, 2019

Last Update Submit

May 11, 2022

Conditions

Keywords

Prostate cancerProstatectomyRobotic surgeryUrinary incontinenceSustainable functional urethral reconstruction

Outcome Measures

Primary Outcomes (1)

  • 1-month urinary continence recovery rates

    Continence defined as daily usage of 0-1 pad with 24-hour pad weights≤50g.

    1 month after catheter removal

Secondary Outcomes (4)

  • Short-term urinary continence recovery

    Within 3 month after catheter removal

  • Peri and postoperative complications

    1-year follow up

  • Post-operative oncological outcomes

    1-year follow up

  • Short-term urinary function and urinary function-related quality of life

    1-week, 2-week, 1-month, 3-month after catheter removal.

Other Outcomes (4)

  • 1-year urinary continence recovery

    1-year from the intervention

  • 1-year urinary function and urinary function-related quality of life

    1-year from the intervention

  • Evaluation of urinary continence with ICIQ-UI-SF

    1-week, 2-week, 1-month, 3-month after catheter removal

  • +1 more other outcomes

Study Arms (2)

SFUR-RARP

EXPERIMENTAL

Patients in which RARP with sustainable functional urethral reconstruction (SFUR) is performed.

Procedure: SFUR-RARP

Standard RARP

ACTIVE COMPARATOR

Patients in which standard RARP is performed.

Procedure: Standard RARP

Interventions

SFUR-RARPPROCEDURE

Robotic-assisted radical prostatectomy with sustainable functional urethral reconstruction (SFUR)

SFUR-RARP
Standard RARPPROCEDURE

Robotic-assisted radical prostatectomy with conventional RARP procedures.

Standard RARP

Eligibility Criteria

Age40 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥40, but ≤75 years old;
  • Histological confirmed prostate cancer;
  • Localized or locally advanced prostate cancer;
  • Presence of urinary continence prior to the procedure;
  • Informed consent signed;

You may not qualify if:

  • Metastatic prostate cancer confirmed by ECT, PSMA or whole-body MRI;
  • Presence of any prostatic surgery(such as transurethral resection, laser therapy, microwave therapy, radiofrequency ablation and so on) prior to the procedure;
  • Radiation therapy of the prostate or pelvis prior to the procedure;
  • Uncontrolled intercurrent illness that would limit compliance with study requirements;
  • Any condition that contraindicates a radical prostatectomy;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital

Shanghai, Shanghai Municipality, 200082, China

Location

Related Publications (5)

  • Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep;62(3):405-17. doi: 10.1016/j.eururo.2012.05.045. Epub 2012 Jun 1.

    PMID: 22749852BACKGROUND
  • Dev HS, Sooriakumaran P, Srivastava A, Tewari AK. Optimizing radical prostatectomy for the early recovery of urinary continence. Nat Rev Urol. 2012 Jan 24;9(4):189-95. doi: 10.1038/nrurol.2012.2.

    PMID: 22270136BACKGROUND
  • Bessede T, Sooriakumaran P, Takenaka A, Tewari A. Neural supply of the male urethral sphincter: comprehensive anatomical review and implications for continence recovery after radical prostatectomy. World J Urol. 2017 Apr;35(4):549-565. doi: 10.1007/s00345-016-1901-8. Epub 2016 Aug 2.

    PMID: 27484205BACKGROUND
  • Pavlovich CP, Rocco B, Druskin SC, Davis JW. Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes. BJU Int. 2017 Aug;120(2):185-196. doi: 10.1111/bju.13852. Epub 2017 Apr 17.

    PMID: 28319318BACKGROUND
  • Bianchi L, Turri FM, Larcher A, De Groote R, De Bruyne P, De Coninck V, Goossens M, D'Hondt F, De Naeyer G, Schatteman P, Mottrie A. A Novel Approach for Apical Dissection During Robot-assisted Radical Prostatectomy: The "Collar" Technique. Eur Urol Focus. 2018 Sep;4(5):677-685. doi: 10.1016/j.euf.2018.01.004. Epub 2018 May 7.

    PMID: 29402756BACKGROUND

MeSH Terms

Conditions

Prostatic NeoplasmsUrinary Incontinence

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yinghao Sun, MD, PHD

    Changhai Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 30, 2019

Study Start

December 8, 2019

Primary Completion

January 10, 2021

Study Completion

September 28, 2021

Last Updated

May 18, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations